These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 25077368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A.
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D levels and other biochemical parameters of mineral bone disorders and their association with diastolic dysfunction and left ventricular mass in young nondiabetic adult patients with chronic kidney disease.
    Sonkar SK, Bhutani M, Sonkar GK, Pandey SK, Chandra S, Bhosale V.
    Saudi J Kidney Dis Transpl; 2017 Jun; 28(4):758-763. PubMed ID: 28748877
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study.
    Shaheen FA, Kurpad R, Al-Sayyari AA, Souqiyyeh MZ, Aljubori H, El Baz T, Kashif W, Tuganbekova S, Kabulbayev K, Jarraya F, Nafar M.
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):290-304. PubMed ID: 26997382
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M, Monier-Faugere MC, Magnusson P, Malluche HH.
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [Abstract] [Full Text] [Related]

  • 13. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A, Ureña-Torres P, Zillikens MC, Bover J, Cohen-Solal M.
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Searching the optimal PTH target range in children undergoing peritoneal dialysis: new insights from international cohort studies.
    Haffner D, Schaefer F.
    Pediatr Nephrol; 2013 Apr; 28(4):537-45. PubMed ID: 22893310
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients.
    Einbinder Y, Benchetrit S, Golan E, Zitman-Gal T.
    Ann Lab Med; 2017 Sep; 37(5):381-387. PubMed ID: 28643486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.